Identification of tumor-specific CD8 T cells with a surface marker

被引：1
|
作者：
Becht, Etienne [1 ]
Newell, Evan W. [1 ]
Simoni, Yannick [1 ]
机构：
[1] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, 8A Biomed Grove, Singapour 138648, Singapore
来源：
M S-MEDECINE SCIENCES | 2018年 / 34卷 / 12期
关键词：
CANCER; BLOCKADE; MASS;
D O I：
10.1051/medsci/2018286
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1032 / 1034
页数：3
相关论文
共 50 条
  • [31] The fate of low affinity tumor-specific CD8+T cells in tumor bearing mice
    Lyman, MA
    Nugent, CT
    Marquardt, KL
    Biggs, JA
    Pamer, EG
    Sherman, LA
    FASEB JOURNAL, 2005, 19 (04): : A361 - A361
  • [32] CD4 antibodies have the potential to amplify tumor-specific CD8 responses
    Schneeberger, A
    Luehrs, P
    Kutil, R
    Stingl, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A36 - A36
  • [33] Characterizing the role of NFAT5 in tumor specific CD8 T cells
    Tille, L.
    Speiser, D. E.
    Verdeil, G.
    SWISS MEDICAL WEEKLY, 2018, 148 : 40S - 40S
  • [34] Population dynamics of tumor-specific CD8 T cell differentiation from plastic to fixed dysfunctional states
    Philip, Mary
    Pilkinton, Mark
    Ramesh, Ram
    McDonnell, Wyatt J.
    Gangula, Rama D.
    Camara, Steven
    Chopra, Abha
    Schietinger, Andrea
    Mallal, Simon Alexander
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [35] Chemical Castration of Melanoma Patients Does Not Increase the Frequency of Tumor-specific CD4 and CD8 T Cells After Peptide Vaccination
    Vence, Luis M.
    Wang, Chiyu
    Pappu, Himabindu
    Anson, Ryan E.
    Patel, Tejal A.
    Miller, Priscilla
    Bassett, Roland
    Lizee, Gregory
    Overwijk, Willem W.
    Komanduri, Krishna
    Benjamin, Cara
    Alvarado, Gladys
    Patel, Sapna P.
    Kim, Kevin
    Papadopoulos, Nicholas E.
    Bedikian, Agop Y.
    Homsi, Jade
    Hwu, Wen-Jen
    Boyd, Richard
    Radvanyi, Laszlo
    Hwu, Patrick
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (04) : 276 - 286
  • [36] Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition
    Abu Eid, Rasha
    Ahmad, Shamim
    Lin, Yuan
    Webb, Mason
    Berrong, Zuzana
    Shrimali, Rajeev
    Kumai, Takumi
    Ananth, Sudha
    Rodriguez, Paulo C.
    Celis, Esteban
    Janik, John
    Mkrtichyan, Mikayel
    Khleif, Samir N.
    CANCER RESEARCH, 2017, 77 (15) : 4135 - 4145
  • [37] Two-Dimensional Label-Free Affinity Analysis of Tumor-Specific CD8 T Cells with a Biomimetic Plasmonic Sensor
    Soler, Maria
    Li, Xiaokang
    John-Herpin, Aurelian
    Schmidt, Julien
    Coukos, George
    Altug, Hatice
    ACS SENSORS, 2018, 3 (11): : 2286 - 2295
  • [38] Differences in the recognition of tumor-specific CD8(+) T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer
    Kono, K
    Ichihara, F
    Iizuka, H
    Sekikawa, T
    Matsumoto, Y
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (06) : 978 - 981
  • [39] Self-tumor-antigen-specific CD8 T cells were suppressed by regulatory T cells
    Maeda, Yuka
    Nishikawa, Hiroyoshi
    Sakaguchi, Shimon
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [40] Tracking tumor-specific CD8+ T cell responses
    Burke, Kelly P.
    Markson, Samuel C.
    Sharpe, Arlene H.
    TRENDS IN IMMUNOLOGY, 2023, 44 (05) : 326 - 328
12345